CTOs on the Move

Prilenia

www.prilenia.com

 
We are a clinical stage biotech startup, led by Michael Hayden, MD, PhD., together with a highly experienced team with a track record of success. Michael is the founder of five biotech companies and was previously President of Global R&D and Chief Scientific Officer at Teva. He has directed the development of multiple innovative drug products leading to 35 approvals between 2012-2018.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Prilenia raised $62.5M on 06/03/2020

Similar Companies

Innomar Strategies

Innomar Strategies, a part of AmerisourceBergen, is Canada`s leading patient support provider for specialty pharmaceuticals. We deliver end-to-end support solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient assistance programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies ensures patients are supported throughout their treatment journey every step of the way.

Makro Scientific

Makro Scientific is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innocoll

A specialty pharmaceutical company focused on the development and commercialization of pharmaceutical technologies to meet important healthcare challenges

Nutra Lab Canada

Nutra Lab Canada Inc. is a Markham, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stern at Home Therapy

Stern At Home Therapy is transforming how outpatient therapy is experienced.